BioLine RX Stock

BioLine RX Dividend

Dividend of BioLine RX (BLRX.TA) as of Mar 19, 2026.

Dividend

0USD

Last updated:

How much dividend does BioLine RX 2026 pay?

According to the latest status from March 2026, BioLine RX paid a total of 0 USD per share in dividends within the last 12 months. With the current BioLine RX price of 0.48 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

Historical BioLine RX Dividends

PaydateDividend

Is the BioLine RX Dividend Safe?

BioLine RX has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding BioLine RX's Dividend Distributions

BioLine RX’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining BioLine RX's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

BioLine RX's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in BioLine RX’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

BioLine RX Stock analysis

What does BioLine RX do? BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe. BioLine RX is one of the most popular companies on Eulerpool.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about BioLine RX stock

BioLine RX is assigned to the 'Health' sector.

Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — BioLine RX